Injectable Bulking Agent Needle Guide

Stopped early · Phase 1

Conditions studied: Urinary Incontinence, Intrinsic Sphincter Deficiency

In brief

The purpose of this study is to evaluate the use of the Needle Guide as an assist in properly guiding an injection needle into the appropriate tissue plane during an injectable bulking agent procedure in women using a FDA approved injectable bulking agent. The injectable bulking agent will be Durasphere EXP.

Key facts

Study ID

NCT00763711

Run by

Carbon Medical Technologies

People needed

17

Starts

2008-06-01

Expected to finish

2009-11-01

Last updated by the study team

2012-01-10

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic Jacksonville — Jacksonville, Florida, United States
• Advanced Urogynecology — West Chester, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.